61 completed, 8 recruiting, 8 unknown, 7 terminated. 91 Phase 3, 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 91 | Completed 61, Recruiting 8, Unknown 8, Terminated 7, Not yet recruiting 4, Withdrawn 3 |
| Phase 2 | 7 | Completed 6, Terminated 1 |
Follow Anemia, Hypochromic: new trials by email Literature Review of Anemia, Hypochromic trials Research Report on Anemia, Hypochromic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose in Patients With Iron Deficiency Anemia Ferric Bepectate IV Injection, Ferric Carboxymaltose Injection [Ferinject], Ferric Carboxymaltose Injection [Injectafer®] - Iron Deficiency Anemia (IDA) | Phase 3 | Not yet recruiting | AFT Pharmaceuticals, Ltd. | 1366 | 2026-12-01 | 2026-08-20 |
| Nutritional Optimization in Anemic Patients Scheduled for Elective Open-Heart Surgery Immune Modulating Formula, Whey Protein, Multivitamins and Iron Supplements - Anemia, Iron Deficiency | Phase 3 | Not yet recruiting | National Institute of Cardiovascular Diseases, Pakistan | 140 | 2026-09-10 | 2026-09-03 |
| How Precision Diets, Through Gut Bacteria, Affect Anemia in Nepalese Adolescent Iron folic acid supplement, Goat liver supplementation, Nutrition education on anemia prevention and control - Anemia | Phase 3 | Not yet recruiting | Southern Medical University, China | 60 | 2026-07-01 | 2026-06-25 |
| Comparison of Ferrous Salt vs. Liposomal Iron in Adult Women With Iron-Deficiency Anemia Oral ferrous fumarate administered every 24 hours, Ferrous fumarate administered orally every 48 hours., Liposomal iron formulation. - Iron-deficiency Anemia (IDA), Hemoglobin | Phase 3 | Not yet recruiting | Hospital General de Mexico | 100 | 2026-05-01 | 2026-04-29 |
| Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study Monofer (iron isomaltoside 1000), Ferrous Sulfate - Peritoneal Dialysis, Anaemia | Phase 3 | Recruiting | Hull University Teaching Hospitals NHS Trust | 30 | 2025-11-13 | 2026-05-06 |
| Co-administration of Calcium and Multiple Micronutrient Supplements for Maternal and Newborn Hemoglobin and Iron Status Concurrent multiple micronutrient and calcium supplementation, Separate multiple micronutrient and calcium supplementation - Anemia, Iron Deficiency | Phase 3 | Recruiting | Johns Hopkins Bloomberg School of Public Health | 3200 | 2025-08-25 | 2026-08-10 |
| Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) Ferric derisomaltose, Placebo - Gynecologic Cancer, Anemia | Phase 3 | Recruiting | AHS Cancer Control Alberta | 82 | 2025-04-08 | 2026-10-28 |
| Effectiveness of Oral Iron Therapy in Iron Deficiency Anemia With Daily vs Alternate Day Dosing Ferrous sulphate - Iron Deficiency Anemia, Iron Deficiency Anemia Treatment | Phase 3 | Completed | University of Child Health Sciences and Children's Hospital, Lahore | 60 | 2025-01-07 | 2026-06-16 |
| Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease ferric citrate, standard of care - Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease | Phase 3 | Withdrawn | Keryx Biopharmaceuticals | 2025-01-01 | 2025-11-20 | |
| Safety and Effectiveness of IHAT in Iron Deficient Pre-menopausal Woman Low dose IHAT, High Dose IHAT, Carob flour - Iron-deficiency | Phase 3 | Completed | RDC Clinical Pty Ltd | 180 | 2024-03-06 | 2025-03-10 |
| Safety and Effectiveness of Iron Hydroxide Adipate Tartrate (IHAT) in Iron Deficient Premenopausal Women Low Dose IHAT, High Dose IHAT, Carob Flour - Iron-deficiency | Phase 3 | Completed | Nemysis Ltd | 180 | 2024-03-05 | 2025-06-04 |
| EffiCacy and sAfEty of Low doSe orAl iRon for Anaemia in IBD Ferrous fumarate syrup 2.5ml/70mg (22.5mg elemental iron), Ferrous fumarate syrup 2.5ml/70mg(45mg elemental iron), Ferrous fumarate syrup 2.5ml/70mg (90mg elemental iron) - Inflammatory Bowel Disease, Iron Deficiency Anemia | Phase 3 | Unknown | Liverpool University Hospitals NHS Foundation Trust | 30 | 2023-10-20 | 2024-03-20 |
| A Study to Compare Liposomal Iron With Ferrous Ascorbate in the Treatment of Iron Deficiency Anemia in Children Ferric Pyrophosphate Liposomal, ferrous ascorbate - Nutritional Anemia | Phase 3 | Unknown | All India Institute of Medical Sciences | 96 | 2023-08-01 | 2023-07-24 |
| Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy Ferric derisomaltose, Ferrous sulfate - Iron Deficiency Anemia, Pregnancy | Phase 3 | Recruiting | Women and Infants Hospital of Rhode Island | 300 | 2023-01-17 | 2025-06-10 |
| Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS Ferric Derisomaltose Injection, Normal saline - Gynecologic Cancer, Anemia, Iron Deficiency | Phase 3 | Unknown | Alberta Health Services, Calgary | 82 | 2022-09-30 | 2022-07-20 |
| IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department Ferric Derisomaltose 1000 Mg in 10 mL INTRAVENOUS SOLUTION [Monoferric], Ferrous Sulfate 65 mg elemental iron (325 mg tablets) - Anemia, Iron Deficiency, Uterine Bleeding | Phase 3 | Recruiting | Baylor College of Medicine | 40 | 2022-09-15 | 2024-12-05 |
| Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease Ferric Citrate 1 GM Oral Tablet [AURYXIA], Placebo - Anemia, Iron Deficiency, Hyperphosphatemia | Phase 3 | Completed | USRC Kidney Research | 289 | 2022-03-30 | 2025-08-29 |
| Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF) Ferric Derisomaltose 1000 Mg in 100 mL INTRAVENOUS SOLUTION [Monoferric], Placebo - Iron-deficiency, Heart Failure With Preserved Ejection Fraction | Phase 2 / Phase 3 | Completed | Massachusetts General Hospital | 65 | 2021-11-26 | 2026-09-04 |
| Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years Ferric Maltol, Ferrous sulfate - Anemia, Iron-deficiency | Phase 3 | Completed | Shield Therapeutics | 65 | 2021-11-03 | 2025-11-10 |
| Safety and Efficacy Study of Ferric Maltol To Treat Iron Deficiency Anaemia in Chinese Patients With Inflammatory Bowel Disease Ferric Maltol, Placebo Oral Capsule - Iron Deficiency Anaemia | Phase 3 | Completed | Jiangsu Aosaikang Pharmaceutical Co., Ltd. | 122 | 2021-09-01 | 2026-07-31 |
Showing 20 of 91. Sign in to see all of them.
Anemia, Iron-Deficiency (91) · Anemia (26) · Iron Deficiencies (24) · Renal Insufficiency, Chronic (10) · Inflammatory Bowel Diseases (8) · Colitis, Ulcerative (4) · Crohn Disease (4) · Heart Diseases (2) · Heart Failure (2) · Heart Failure, Systolic (2) · Hyperphosphatemia (2) · Hypophosphatemia (2) · Renal Insufficiency (2) · Atrial Fibrillation (1) · Cardiovascular Diseases (1)
Hematologic Diseases (91) · Hemic and Lymphatic Diseases (91) · Iron Metabolism Disorders (91) · Metabolic Diseases (91) · Nutritional and Metabolic Diseases (91) · Iron Deficiencies (67) · Anemia (65) · Pathological Conditions, Signs and Symptoms (15) · Pathologic Processes (14) · Female Urogenital Diseases and Pregnancy Complications (13) · Urogenital Diseases (13) · Disease Attributes (12) · Female Urogenital Diseases (12) · Kidney Diseases (11)
ferric carboxymaltose (24) · ferrous sulfate (18) · Ferric Oxide, Saccharated (11) · Ferrosoferric Oxide (11) · ferric derisomaltose (11) · iron isomaltoside 1000 (11) · Iron (10) · Iron-Dextran Complex (10) · ferric maltol (7) · Saline Solution (5) · Sodium Chloride (4) · ferric trimaltol (4) · ferrous fumarate (4) · Ascorbic Acid (3) · ferric citrate (3)
Pharmacosmos A/S (11) · AMAG Pharmaceuticals, Inc. (9) · American Regent, Inc. (5) · Shield Therapeutics (5) · Vifor Pharma (5) · Baylor College of Medicine (2) · Zeria Pharmaceutical (2) · AFT Pharmaceuticals, Ltd. (1) · AHS Cancer Control Alberta (1) · Alberta Health Services, Calgary (1) · All India Institute of Medical Sciences (1) · American University of Beirut Medical Center (1) · Ann & Robert H Lurie Children's Hospital of Chicago (1) · Auerbach Hematology Oncology Associates P C (1) · Casa Espirita Terra de Ismael (1)
United States (36) · Poland (11) · Germany (10) · Canada (7) · Hungary (7) · Denmark (6) · United Kingdom (6) · Australia (5) · India (5) · Latvia (5) · Lithuania (5) · Spain (5) · France (4) · Italy (4) · Mexico (4)
Nicholas Mallard, PhD (2) · Adrian F Hernandez, MD (1) · Ala Sharara, MD (1) · Amanda Palmer, PhD (1) · Amanda Rao, PhD (1) · Antonio Di Sabatino, MD (1) · Bambang B Siswanto, Professor (1) · Bjorn Backe, MD PhD (1) · Carla Cerami, MD, PhD (1) · Christoph Gasche, Professor (1) · David Kearney, MD (1) · Deirdre Lyell (1) · Dr.Yulia Lin (1)
PMID 19920054, PMID 25545376, PMID 27237709, PMID 32016310, PMID 19875408, PMID 20016011, PMID 24297872, PMID 24891437, PMID 25639592, PMID 26028263, PMID 26843085, PMID 27068478, PMID 28095881, PMID 28339831, PMID 29958570, PMID 30518682, PMID 31243803, PMID 32049331, PMID 32444411, PMID 33245866, PMID 34003690, PMID 34029682, PMID 35771891, PMID 36578916, PMID 36874582, PMID 36948568, PMID 37598795, PMID 37632463, PMID 37945297, PMID 38250799, PMID 39890013, PMID 40576086, PMID 41137844, PMID 41860281, PMID 42132028, PMID 42733564, PMID 42767731
2008 (1), 2014 (1), 2016 (1), K12HD103084 (1), K23HL132001 (1), R01HL151841 (1)